Clinical Trials Sponsored by Roseli Shavitt

Total 819 results

University of Michigan Rogel Cancer Center

Completed

Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast Cancer

Metastatic Breast Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Combination Study of Revlimid®, Velcade® Dexamethasone and Doxil® (RVDD)for Newly Diagnosed Multiple Myeloma (RVDD)

Multiple Myeloma

United States, Canada
University of Michigan Rogel Cancer Center

Completed

A Study of Individualized Stereotactic Body Radiation Therapy (SBRT) for Intrahepatic Cancer

Liver Cancer | Hepatocellular Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant

Multiple Myeloma | Lymphoma, Low-Grade | Lymphocytic Leukemia, Chronic

United States
University of Michigan Rogel Cancer Center

Terminated

A Pilot Study to Evaluate Neurocognitive Injury and Longitudinal Changes in White Matter During Radiation Therapy in Children With Primary Brain Tumors

Brain Tumor, Primary

United States
University of Michigan Rogel Cancer Center

Terminated

Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies.

Prostate Cancer | Bladder Cancer | Urothelial Carcinoma | Non-Small-Cell Lung Carcinoma

United States
University of Michigan Rogel Cancer Center

Completed

A Study Using Cone Beam CT for Head and Neck Cancer

Head and Neck Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Tissue Procurement Protocol for Patients Undergoing Neoadjuvant Systemic Therapy for Breast Cancer

Breast Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Loss of Grip Strength, BMI, and Adjuvant Endocrine Therapy Breast Cancer (LOGRIBMET)

Obesity | Breast Cancer | Arthralgia

United States
University of Michigan Rogel Cancer Center

Completed

The Use of Etanercept Enbrel as Sole Treatment for Grade I Acute Graft Versus Host Disease

Acute Graft Versus Host Disease

United States
University of Michigan Rogel Cancer Center

Terminated

A Pilot Study Assessing Intra-Metastasis Administration of Autologous KLH-pulsed Dendritic Cells With Tumoral Radiation Therapy in Patients With Metastatic Pancreatic Carcinoma

Metastatic Pancreatic Carcinoma

United States
University of Michigan Rogel Cancer Center

Completed

Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sarcoma

Sarcoma, Soft Tissue

United States
University of Michigan Rogel Cancer Center

Completed

A Phase II Study of Oral Cyclophosphamide and Sirolimus (OCR) in Advanced Sarcoma (OCR)

Osteosarcoma

United States
University of Michigan Rogel Cancer Center

Completed

Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer

Colorectal Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Tetrathiomolybdate in Hormone Refractory Prostate Cancer

Prostate Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the Bladder

Bladder Cancer

United States
University of Michigan Rogel Cancer Center

Withdrawn

A Randomized Comparative Study of a Weekly Versus Every Other Week Nurse Practitioner-led Symptom Management Clinic for Head and Neck Cancer Patients Undergoing Concurrent Chemotherapy and Radiation

Head and Neck Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Cross-Sectional Study of Oral Health in Patients After Parotid-Sparing Radiation Therapy for Head and Neck Cancer

Head and Neck Cancer

United States
University of Michigan Rogel Cancer Center

Terminated

Trial Evaluating Gleevec in Patients With Anaplastic Thyroid Carcinoma

Thyroid Cancer

United States
University of Michigan Rogel Cancer Center

Terminated

Use of Trastuzumab to Induce Increased ER Expression in ER-negative/Low, Her-2/Neu Positive Breast Cancer

Breast Cancer

United States
University of Michigan Rogel Cancer Center

Completed

The Use of Etanercept (Enbrel®) in the Treatment of Acute Graft-Versus-Host Disease

Graft-Versus-Host Disease

United States
University of Michigan Rogel Cancer Center

Completed

Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma

Colorectal Carcinoma

United States
University of Michigan Rogel Cancer Center

Completed

Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple Myeloma

Multiple Myeloma

United States
University of Michigan Rogel Cancer Center

Terminated

Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced NSCLC Through Gene Expression Profiling

Advanced Non-Small Cell Lung Cancer

United States
University of Michigan Rogel Cancer Center

Recruiting

Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer (ARTHOUSE)

Oropharynx Cancer | HPV-Related Carcinoma

United States
University of Michigan Rogel Cancer Center

Not yet recruiting

Breast Cancer Resiliency Through Exercise Program (B-REP) (B-REP)

Breast Cancer Female

United States
University of Michigan Rogel Cancer Center

Not yet recruiting

Effect of Pre-operative Virtual Visits on Patients With Head and Neck Cancer Undergoing Surgery

Head and Neck Cancer
University of Michigan Rogel Cancer Center

Not yet recruiting

Feasibility of Virtual, Tailored, Music-Based Relaxation for Anxiety in Adolescent and Young Adult Cancer Survivors

Anxiety

United States
University of Michigan Rogel Cancer Center

Recruiting

A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma

Hepatocellular Carcinoma

United States
University of Michigan Rogel Cancer Center

Recruiting

Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Breast Cancer

Breast Cancer

United States
University of Michigan Rogel Cancer Center

Recruiting

Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])

Prostate Cancer

United States
University of Michigan Rogel Cancer Center

Recruiting

Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors

Neuroendocrine Tumors

United States
University of Michigan Rogel Cancer Center

Recruiting

Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

Metastatic Thyroid Cancer

United States
University of Michigan Rogel Cancer Center

Recruiting

Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients

Hematopoietic Stem Cell Transplantation

United States
University of Michigan Rogel Cancer Center

Active, not recruiting

Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I)

Metastatic Melanoma | Liver Metastases | Melanoma, Mucosal | Melanoma, Ocular | Melanoma, Cutaneous

United States
University of Michigan Rogel Cancer Center

Terminated

Multi-center Trial of ESK981 in Combination With Nivolumab in Patients With Metastatic Renal Cell Carcinoma (ERICA)

Renal Cell Carcinoma, Metastatic

United States
University of Michigan Rogel Cancer Center

Completed

FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE)

Prostate Cancer

United States
University of Michigan Rogel Cancer Center

Completed

A Pilot Study of Roadmap 2.0 in Oncology Caregivers and Patients

Quality of Life | Cancer

United States
University of Michigan Rogel Cancer Center

Suspended

Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Undergoing Surgery for Newly Diagnosed Glioblastoma

Glioblastoma

United States
University of Michigan Rogel Cancer Center

Terminated

Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast Cancer

Metastatic Breast Cancer

United States
University of Michigan Rogel Cancer Center

Completed

A Pilot Study of Response-Driven Adaptive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States
University of Michigan Rogel Cancer Center

Completed

Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Organ Preservation In Adults With Advanced Laryngeal Cancer

Laryngeal Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Phase II Treatment Stratification Trial Using Neck Dissection-Driven Selection to Improve Quality of Life for Low Risk Patients With HPV+ Oropharyngeal Squamous Cell Cancer

Oropharyngeal Squamous Cell Cancer

United States
University of Michigan Rogel Cancer Center

Terminated

Radiolabeled Gallium-68 (68Ga-PSMA) for PET/CT Imaging to Detect Prostate Cancer

Prostate Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies

Hematologic Malignancies | Graft-Versus-Host Disease | Relapse

United States
University of Michigan Rogel Cancer Center

Completed

Phase Ib/II Trial of Interleukin-2 and PD-1 Checkpoint Inhibitor, Nivolumab In Metastatic Clear Cell Renal Cell Cancer

Renal Cell Carcinoma

United States
University of Michigan Rogel Cancer Center

Terminated

Study of Radiation (RT) Concurrent With Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (SCC)

Head and Neck Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Reduced-intensity Therapy for Oropharyngeal Cancer in Non-smoking HPV-16 Positive Patients

HPV | Squamous Cell Carcinoma of the Oropharynx

United States
University of Michigan Rogel Cancer Center

Withdrawn

Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate Cancer

Prostate Cancer

United States
University of Michigan Rogel Cancer Center

Withdrawn

Bortezomib in Combination With Ibrutinib in Ibrutinib Relapsed Mantle Cell Lymphoma

Mantle Cell Lymphoma

United States

3

Subscribe